Post Profile






Levemir(R) Once-Daily Substantially Lowered Average Blood Sugar Levels Of Patients With Type 2 Diabetes In TITRATE(R) Study

Novo Nordisk announced results from the TITRATE® study showing that Levemir® (insulin detemir [rDNA origin] injection), taken once-daily, substantially lowered average blood sugar. Type 2 diabetes patients took a more active role in their treatment by adjusting their own dosing, after being trained and given an adjustment schedule by their physician.
read more

share

Related Posts


Levemir(R) Demonstrates A 24-hour Duration Of Action And Significant Weight Loss In Obese Patients - New Studies Announced

Health : Medical News Today

Data released at the European Association for the Study of Diabetes (EASD) Annual Meeting concludes that Levemir® (insulin detemir [rDNA origin] injection) is a once-daily treatment for diabetes patients after demonstrating a 24-hou...

Study Shows Gradual Addition Of NovoLog® At Mealtime Can Reduce A1c In Type 2 Diabetes Patients

Health : Medical News Today

Novo Nordisk announced results of its STEPwise™ trial, which identified a method of intensifying insulin treatment with NovoLog® (insulin aspart [rDNA origin] injection). The study, presented at the American Diabetes Association (AD...

New Data Show Victoza(R) Helped Reduce Blood Sugar When Patients With Type 2 Diabetes Switched From Sitagliptin Or Exenatide

Health : Medical News Today

Today at the 71st Annual Scientific Sessions of the American Diabetes Association (ADA), Novo Nordisk presented data from two extension studies which show that Victoza® (liraglutide [rDNA origin] injection), taken once-daily, in com...

New Data Shows Victoza(R) Helped Reduce Blood Sugar When Patients With Type 2 Diabetes Switched From Sitagliptin Or Exenatide

Health : Medical News Today

Novo Nordisk will present data from two extension studies at the 71st Annual Scientific Sessions of the American Diabetes Association (ADA) which show that Victoza® (liraglutide [rDNA origin] injection), taken once-daily, in combina...

New Data From Head-To-Head Study Confirms Once-Daily Levemir(R) Is As Effective As Glargine Over A 24-hour Period In Subjects With Type 2 Diabetes

Health : Medical News Today

A head-to-head study announced at the American Diabetes Association (ADA) meeting demonstrated that Levemir® (insulin detemir [rDNA origin] injection) can be used once daily and had a comparable blood glucose response to insulin gla...

Comments


Copyright © 2016 Regator, LLC